Is Chlormadinone + Ethinylestradiol registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Chlormadinone + Ethinylestradiol, including BELARA 0.03MG/2MG F.C.TABLET (2,0.03 mg,mg, Film-coated tablet, SAR 65.70).

Active substances

Chlormadinone + Ethinylestradiol

SFDA 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
BELARA 0.03MG/2MG F.C.TABLET	2,0.03 mg,mg	Film-coated tablet · Oral use	63 Blister	SAR 65.70	NCE · Prescription	AJA PHARMACEUTICAL INDUSTRIES	Valid
BELARA 0.03MG/2MG F.C.TABLET	2 , 0.03 mg	Film-coated tablet · Oral use	21 Blister	SAR 21.90	NCE · Prescription	AJA PHARMACEUTICAL INDUSTRIES	Withdrawn by MAH · Not Marketed

Indications — CHI Daman Drug Formulary

ENDOMETRIOSIS; HYPERPROLACTINEMIA; MENOPAUSE; MENSTRUAL DISORDERS

Components

Ethinylestradiol

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.